메뉴 건너뛰기




Volumn 96, Issue 2, 2014, Pages 159-161

Lack of drug dosing guidelines for critically ill patients receiving continuous renal replacement therapy

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIINFECTIVE AGENT; SEDATIVE AGENT; VASOACTIVE AGENT;

EID: 84904857125     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2014.102     Document Type: Article
Times cited : (28)

References (5)
  • 1
    • 84884342549 scopus 로고    scopus 로고
    • KDIGO. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury
    • KDIGO. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. Suppl. 2, 1-138 (2012
    • (2012) Kidney Int. Suppl , vol.2 , pp. 1-138
  • 2
    • 70350219254 scopus 로고    scopus 로고
    • When to conduct a renal impairment study during drug development: Us food and drug administration perspective
    • Huang, S.M., Temple, R., Xiao, S., Zhang, L. & Lesko, L.J. When to conduct a renal impairment study during drug development: US Food and Drug Administration perspective. Clin. Pharmacol. Ther. 86, 475-479 (2009
    • (2009) Clin. Pharmacol. Ther , vol.86 , pp. 475-479
    • Huang, S.M.1    Temple, R.2    Xiao, S.3    Zhang, L.4    Lesko, L.J.5
  • 3
    • 70350224115 scopus 로고    scopus 로고
    • Challenges in developing evidence-based drug dosing guidelines for adults and children receiving renal replacement therapy
    • Mueller, B.A. & Smoyer, W.E. Challenges in developing evidence-based drug dosing guidelines for adults and children receiving renal replacement therapy. Clin. Pharmacol. Ther. 86, 479-482 (2009
    • (2009) Clin. Pharmacol. Ther , vol.86 , pp. 479-482
    • Mueller, B.A.1    Smoyer, W.E.2
  • 4
    • 1542287262 scopus 로고    scopus 로고
    • Drug dosing during intermittent hemodialysis and continuous renal replacement therapy: Special considerations in pediatric patients
    • Veltri, M.A., Neu, A.M., Fivush, B.A., Parekh, R.S. & Furth, S.L. Drug dosing during intermittent hemodialysis and continuous renal replacement therapy: Special considerations in pediatric patients. Paediatr. Drugs 6, 45-65 (2004
    • (2004) Paediatr. Drugs , vol.6 , pp. 45-65
    • Veltri, M.A.1    Neu, A.M.2    Fivush, B.A.3    Parekh, R.S.4    Furth, S.L.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.